Definium Therapeutics, Inc. <DFTX.O>: Wells Fargo raises target price to $72 from $68
DFTX•Related News
Abeona Q2 FY26 net loss widens to $20.2 million; revenue rises 31% Q/Q to $11.4 million
ABEO•
Cabaletta Bio posts corporate presentation on rese-cel CD19 CAR-T program for autoimmune diseases
CABA•
Indonesia Energy drills K-29 well past 2,500 feet, targets 3,400-foot total depth
INDO•
Reborn Coffee to improve margins with AI forecasting and in-house logistics through unit
REBN•
Intuitive Machines Q2 revenue jumps on spacecraft production
LUNR•